nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluconazole—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.571	1	CiPCiCtD
Fluconazole—CYP11B1—Hydrocortisone—psoriasis	0.0672	0.211	CbGbCtD
Fluconazole—CYP3A5—Beclomethasone—psoriasis	0.0266	0.0836	CbGbCtD
Fluconazole—CYP3A7—Hydrocortisone—psoriasis	0.0113	0.0356	CbGbCtD
Fluconazole—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0113	0.0356	CbGbCtD
Fluconazole—CYP3A7—Cyclosporine—psoriasis	0.0107	0.0336	CbGbCtD
Fluconazole—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0107	0.0336	CbGbCtD
Fluconazole—CYP3A5—Mycophenolate mofetil—psoriasis	0.0106	0.0333	CbGbCtD
Fluconazole—CYP2C19—Cholecalciferol—psoriasis	0.00986	0.031	CbGbCtD
Fluconazole—CYP3A4—Calcitriol—psoriasis	0.00926	0.0291	CbGbCtD
Fluconazole—CYP3A5—Hydrocortisone—psoriasis	0.00851	0.0267	CbGbCtD
Fluconazole—CYP2C9—Cholecalciferol—psoriasis	0.0082	0.0257	CbGbCtD
Fluconazole—CYP3A5—Cyclosporine—psoriasis	0.00803	0.0252	CbGbCtD
Fluconazole—CYP3A4—Methoxsalen—psoriasis	0.0072	0.0226	CbGbCtD
Fluconazole—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00705	0.0221	CbGbCtD
Fluconazole—CYP3A7—Dexamethasone—psoriasis	0.00705	0.0221	CbGbCtD
Fluconazole—ABCB1—Mycophenolate mofetil—psoriasis	0.0069	0.0217	CbGbCtD
Fluconazole—CYP2C19—Prednisone—psoriasis	0.00684	0.0215	CbGbCtD
Fluconazole—CYP2C19—Cyclosporine—psoriasis	0.00648	0.0203	CbGbCtD
Fluconazole—ABCB1—Betamethasone—psoriasis	0.00592	0.0186	CbGbCtD
Fluconazole—ABCB1—Prednisolone—psoriasis	0.00584	0.0183	CbGbCtD
Fluconazole—ABCB1—Hydrocortisone—psoriasis	0.00554	0.0174	CbGbCtD
Fluconazole—ABCB1—Prednisone—psoriasis	0.00552	0.0173	CbGbCtD
Fluconazole—CYP2C9—Cyclosporine—psoriasis	0.00539	0.0169	CbGbCtD
Fluconazole—CYP3A5—Dexamethasone—psoriasis	0.00529	0.0166	CbGbCtD
Fluconazole—ABCB1—Cyclosporine—psoriasis	0.00523	0.0164	CbGbCtD
Fluconazole—CYP3A4—Cholecalciferol—psoriasis	0.00477	0.015	CbGbCtD
Fluconazole—CYP2C19—Dexamethasone—psoriasis	0.00427	0.0134	CbGbCtD
Fluconazole—CYP3A4—Mycophenolate mofetil—psoriasis	0.00413	0.013	CbGbCtD
Fluconazole—CYP3A4—Triamcinolone—psoriasis	0.00413	0.013	CbGbCtD
Fluconazole—CYP2C9—Dexamethasone—psoriasis	0.00355	0.0111	CbGbCtD
Fluconazole—CYP3A4—Betamethasone—psoriasis	0.00355	0.0111	CbGbCtD
Fluconazole—CYP3A4—Prednisolone—psoriasis	0.0035	0.011	CbGbCtD
Fluconazole—ABCB1—Dexamethasone—psoriasis	0.00344	0.0108	CbGbCtD
Fluconazole—CYP3A4—Hydrocortisone—psoriasis	0.00332	0.0104	CbGbCtD
Fluconazole—CYP3A4—Prednisone—psoriasis	0.0033	0.0104	CbGbCtD
Fluconazole—CYP3A4—Cyclosporine—psoriasis	0.00313	0.00984	CbGbCtD
Fluconazole—ABCB1—Methotrexate—psoriasis	0.00277	0.00869	CbGbCtD
Fluconazole—CYP3A4—Dexamethasone—psoriasis	0.00206	0.00648	CbGbCtD
Fluconazole—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.00057	0.0587	CbGpPWpGaD
Fluconazole—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.000514	0.0529	CbGpPWpGaD
Fluconazole—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000481	0.0495	CbGpPWpGaD
Fluconazole—CYP11B1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000474	0.0489	CbGpPWpGaD
Fluconazole—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000468	0.0483	CbGpPWpGaD
Fluconazole—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000412	0.0424	CbGpPWpGaD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—IVL—psoriasis	0.000402	0.0414	CbGpPWpGaD
Fluconazole—CYP11B1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00039	0.0402	CbGpPWpGaD
Fluconazole—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000318	0.0328	CbGpPWpGaD
Fluconazole—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00029	0.0299	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—IL22—psoriasis	0.000249	0.0257	CbGpPWpGaD
Fluconazole—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000237	0.0244	CbGpPWpGaD
Fluconazole—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000233	0.0241	CbGpPWpGaD
Fluconazole—CYP11B1—Biological oxidations—CYP2S1—psoriasis	0.000207	0.0213	CbGpPWpGaD
Fluconazole—CYP11B1—Metapathway biotransformation—CYP2S1—psoriasis	0.000204	0.021	CbGpPWpGaD
Fluconazole—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000192	0.0198	CbGpPWpGaD
Fluconazole—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000191	0.0197	CbGpPWpGaD
Fluconazole—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000171	0.0176	CbGpPWpGaD
Fluconazole—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000169	0.0174	CbGpPWpGaD
Fluconazole—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000139	0.0143	CbGpPWpGaD
Fluconazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000132	0.0136	CbGpPWpGaD
Fluconazole—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00013	0.0134	CbGpPWpGaD
Fluconazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000121	0.0124	CbGpPWpGaD
Fluconazole—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000119	0.0123	CbGpPWpGaD
Fluconazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000107	0.011	CbGpPWpGaD
Fluconazole—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000103	0.0106	CbGpPWpGaD
Fluconazole—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.000102	0.0105	CbGpPWpGaD
Fluconazole—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.0001	0.0104	CbGpPWpGaD
Fluconazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	9.77e-05	0.0101	CbGpPWpGaD
Fluconazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	7.95e-05	0.00819	CbGpPWpGaD
Fluconazole—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	7.84e-05	0.00809	CbGpPWpGaD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—NFKBIA—psoriasis	7.43e-05	0.00765	CbGpPWpGaD
Fluconazole—CYP3A5—Biological oxidations—CYP2S1—psoriasis	7.36e-05	0.00759	CbGpPWpGaD
Fluconazole—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	7.26e-05	0.00748	CbGpPWpGaD
Fluconazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	6.44e-05	0.00664	CbGpPWpGaD
Fluconazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	6.36e-05	0.00655	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	6.12e-05	0.00631	CbGpPWpGaD
Fluconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.93e-05	0.00611	CbGpPWpGaD
Fluconazole—CYP2C19—Biological oxidations—CYP2S1—psoriasis	5.69e-05	0.00587	CbGpPWpGaD
Fluconazole—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	5.61e-05	0.00579	CbGpPWpGaD
Fluconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.54e-05	0.00571	CbGpPWpGaD
Fluconazole—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	5.52e-05	0.00569	CbGpPWpGaD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—CXCL8—psoriasis	5.3e-05	0.00546	CbGpPWpGaD
Fluconazole—CYP2C9—Biological oxidations—CYP2S1—psoriasis	5.19e-05	0.00535	CbGpPWpGaD
Fluconazole—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	5.12e-05	0.00528	CbGpPWpGaD
Fluconazole—Constipation—Mycophenolate mofetil—psoriasis	4.88e-05	0.000486	CcSEcCtD
Fluconazole—Feeling abnormal—Cyclosporine—psoriasis	4.82e-05	0.000481	CcSEcCtD
Fluconazole—Insomnia—Prednisolone—psoriasis	4.82e-05	0.00048	CcSEcCtD
Fluconazole—Alopecia—Prednisone—psoriasis	4.81e-05	0.00048	CcSEcCtD
Fluconazole—Hepatobiliary disease—Methotrexate—psoriasis	4.8e-05	0.000478	CcSEcCtD
Fluconazole—Gastrointestinal pain—Cyclosporine—psoriasis	4.79e-05	0.000477	CcSEcCtD
Fluconazole—Dizziness—Mycophenolic acid—psoriasis	4.78e-05	0.000477	CcSEcCtD
Fluconazole—Paraesthesia—Prednisolone—psoriasis	4.78e-05	0.000476	CcSEcCtD
Fluconazole—Mental disorder—Prednisone—psoriasis	4.77e-05	0.000476	CcSEcCtD
Fluconazole—Malnutrition—Prednisone—psoriasis	4.74e-05	0.000472	CcSEcCtD
Fluconazole—CYP11B1—Corticotropin-releasing hormone—NFKB1—psoriasis	4.74e-05	0.00488	CbGpPWpGaD
Fluconazole—Musculoskeletal discomfort—Hydrocortisone—psoriasis	4.74e-05	0.000472	CcSEcCtD
Fluconazole—Hyperhidrosis—Triamcinolone—psoriasis	4.73e-05	0.000472	CcSEcCtD
Fluconazole—Agranulocytosis—Methotrexate—psoriasis	4.73e-05	0.000472	CcSEcCtD
Fluconazole—ABCB1—Allograft Rejection—HLA-C—psoriasis	4.72e-05	0.00487	CbGpPWpGaD
Fluconazole—Convulsion—Dexamethasone—psoriasis	4.72e-05	0.00047	CcSEcCtD
Fluconazole—Convulsion—Betamethasone—psoriasis	4.72e-05	0.00047	CcSEcCtD
Fluconazole—Feeling abnormal—Mycophenolate mofetil—psoriasis	4.7e-05	0.000469	CcSEcCtD
Fluconazole—Insomnia—Hydrocortisone—psoriasis	4.7e-05	0.000469	CcSEcCtD
Fluconazole—Hypertension—Dexamethasone—psoriasis	4.7e-05	0.000468	CcSEcCtD
Fluconazole—Hypertension—Betamethasone—psoriasis	4.7e-05	0.000468	CcSEcCtD
Fluconazole—ABCB1—Allograft Rejection—IL13—psoriasis	4.69e-05	0.00484	CbGpPWpGaD
Fluconazole—Paraesthesia—Hydrocortisone—psoriasis	4.67e-05	0.000465	CcSEcCtD
Fluconazole—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	4.67e-05	0.000465	CcSEcCtD
Fluconazole—Urticaria—Cyclosporine—psoriasis	4.65e-05	0.000463	CcSEcCtD
Fluconazole—Myalgia—Betamethasone—psoriasis	4.64e-05	0.000462	CcSEcCtD
Fluconazole—Myalgia—Dexamethasone—psoriasis	4.64e-05	0.000462	CcSEcCtD
Fluconazole—Body temperature increased—Cyclosporine—psoriasis	4.63e-05	0.000461	CcSEcCtD
Fluconazole—Abdominal pain—Cyclosporine—psoriasis	4.63e-05	0.000461	CcSEcCtD
Fluconazole—Vomiting—Mycophenolic acid—psoriasis	4.6e-05	0.000458	CcSEcCtD
Fluconazole—Discomfort—Betamethasone—psoriasis	4.58e-05	0.000456	CcSEcCtD
Fluconazole—Discomfort—Dexamethasone—psoriasis	4.58e-05	0.000456	CcSEcCtD
Fluconazole—Dyspepsia—Hydrocortisone—psoriasis	4.58e-05	0.000456	CcSEcCtD
Fluconazole—Rash—Mycophenolic acid—psoriasis	4.56e-05	0.000454	CcSEcCtD
Fluconazole—Dermatitis—Mycophenolic acid—psoriasis	4.56e-05	0.000454	CcSEcCtD
Fluconazole—Pain—Prednisolone—psoriasis	4.55e-05	0.000454	CcSEcCtD
Fluconazole—Urticaria—Mycophenolate mofetil—psoriasis	4.54e-05	0.000452	CcSEcCtD
Fluconazole—Headache—Mycophenolic acid—psoriasis	4.53e-05	0.000452	CcSEcCtD
Fluconazole—Decreased appetite—Hydrocortisone—psoriasis	4.52e-05	0.000451	CcSEcCtD
Fluconazole—Pharyngitis—Methotrexate—psoriasis	4.52e-05	0.00045	CcSEcCtD
Fluconazole—Body temperature increased—Mycophenolate mofetil—psoriasis	4.51e-05	0.00045	CcSEcCtD
Fluconazole—Abdominal pain—Mycophenolate mofetil—psoriasis	4.51e-05	0.00045	CcSEcCtD
Fluconazole—Urinary tract disorder—Methotrexate—psoriasis	4.5e-05	0.000448	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Hydrocortisone—psoriasis	4.49e-05	0.000447	CcSEcCtD
Fluconazole—Fatigue—Hydrocortisone—psoriasis	4.48e-05	0.000447	CcSEcCtD
Fluconazole—Urethral disorder—Methotrexate—psoriasis	4.46e-05	0.000445	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Triamcinolone—psoriasis	4.46e-05	0.000445	CcSEcCtD
Fluconazole—Pain—Hydrocortisone—psoriasis	4.45e-05	0.000443	CcSEcCtD
Fluconazole—Anaphylactic shock—Dexamethasone—psoriasis	4.44e-05	0.000443	CcSEcCtD
Fluconazole—Anaphylactic shock—Betamethasone—psoriasis	4.44e-05	0.000443	CcSEcCtD
Fluconazole—Insomnia—Triamcinolone—psoriasis	4.43e-05	0.000441	CcSEcCtD
Fluconazole—Ill-defined disorder—Prednisone—psoriasis	4.4e-05	0.000438	CcSEcCtD
Fluconazole—Paraesthesia—Triamcinolone—psoriasis	4.4e-05	0.000438	CcSEcCtD
Fluconazole—Feeling abnormal—Prednisolone—psoriasis	4.39e-05	0.000437	CcSEcCtD
Fluconazole—Visual impairment—Methotrexate—psoriasis	4.39e-05	0.000437	CcSEcCtD
Fluconazole—Anaemia—Prednisone—psoriasis	4.38e-05	0.000437	CcSEcCtD
Fluconazole—Nervous system disorder—Dexamethasone—psoriasis	4.36e-05	0.000434	CcSEcCtD
Fluconazole—Nervous system disorder—Betamethasone—psoriasis	4.36e-05	0.000434	CcSEcCtD
Fluconazole—Agitation—Prednisone—psoriasis	4.36e-05	0.000434	CcSEcCtD
Fluconazole—Thrombocytopenia—Dexamethasone—psoriasis	4.35e-05	0.000434	CcSEcCtD
Fluconazole—Thrombocytopenia—Betamethasone—psoriasis	4.35e-05	0.000434	CcSEcCtD
Fluconazole—Angioedema—Prednisone—psoriasis	4.33e-05	0.000432	CcSEcCtD
Fluconazole—ABCB1—Allograft Rejection—IL17A—psoriasis	4.32e-05	0.00445	CbGpPWpGaD
Fluconazole—Hypersensitivity—Cyclosporine—psoriasis	4.31e-05	0.00043	CcSEcCtD
Fluconazole—Dyspepsia—Triamcinolone—psoriasis	4.31e-05	0.00043	CcSEcCtD
Fluconazole—Erythema multiforme—Methotrexate—psoriasis	4.3e-05	0.000429	CcSEcCtD
Fluconazole—Nausea—Mycophenolic acid—psoriasis	4.3e-05	0.000428	CcSEcCtD
Fluconazole—Hyperhidrosis—Betamethasone—psoriasis	4.3e-05	0.000428	CcSEcCtD
Fluconazole—Hyperhidrosis—Dexamethasone—psoriasis	4.3e-05	0.000428	CcSEcCtD
Fluconazole—Feeling abnormal—Hydrocortisone—psoriasis	4.29e-05	0.000427	CcSEcCtD
Fluconazole—Malaise—Prednisone—psoriasis	4.28e-05	0.000426	CcSEcCtD
Fluconazole—Vertigo—Prednisone—psoriasis	4.26e-05	0.000424	CcSEcCtD
Fluconazole—Eye disorder—Methotrexate—psoriasis	4.25e-05	0.000424	CcSEcCtD
Fluconazole—Gastrointestinal pain—Hydrocortisone—psoriasis	4.25e-05	0.000424	CcSEcCtD
Fluconazole—Anorexia—Dexamethasone—psoriasis	4.24e-05	0.000422	CcSEcCtD
Fluconazole—Anorexia—Betamethasone—psoriasis	4.24e-05	0.000422	CcSEcCtD
Fluconazole—Urticaria—Prednisolone—psoriasis	4.23e-05	0.000422	CcSEcCtD
Fluconazole—Cardiac disorder—Methotrexate—psoriasis	4.23e-05	0.000421	CcSEcCtD
Fluconazole—Fatigue—Triamcinolone—psoriasis	4.22e-05	0.000421	CcSEcCtD
Fluconazole—Hypersensitivity—Mycophenolate mofetil—psoriasis	4.21e-05	0.000419	CcSEcCtD
Fluconazole—Asthenia—Cyclosporine—psoriasis	4.2e-05	0.000418	CcSEcCtD
Fluconazole—Pain—Triamcinolone—psoriasis	4.19e-05	0.000417	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—NDUFA5—psoriasis	4.16e-05	0.00429	CbGpPWpGaD
Fluconazole—Pruritus—Cyclosporine—psoriasis	4.14e-05	0.000413	CcSEcCtD
Fluconazole—Urticaria—Hydrocortisone—psoriasis	4.13e-05	0.000412	CcSEcCtD
Fluconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.13e-05	0.00426	CbGpPWpGaD
Fluconazole—Angiopathy—Methotrexate—psoriasis	4.13e-05	0.000412	CcSEcCtD
Fluconazole—Immune system disorder—Methotrexate—psoriasis	4.11e-05	0.00041	CcSEcCtD
Fluconazole—Body temperature increased—Hydrocortisone—psoriasis	4.11e-05	0.00041	CcSEcCtD
Fluconazole—Abdominal pain—Hydrocortisone—psoriasis	4.11e-05	0.00041	CcSEcCtD
Fluconazole—Convulsion—Prednisone—psoriasis	4.11e-05	0.000409	CcSEcCtD
Fluconazole—Mediastinal disorder—Methotrexate—psoriasis	4.1e-05	0.000409	CcSEcCtD
Fluconazole—Asthenia—Mycophenolate mofetil—psoriasis	4.1e-05	0.000408	CcSEcCtD
Fluconazole—Hypertension—Prednisone—psoriasis	4.09e-05	0.000408	CcSEcCtD
Fluconazole—Chills—Methotrexate—psoriasis	4.08e-05	0.000407	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Betamethasone—psoriasis	4.05e-05	0.000403	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Dexamethasone—psoriasis	4.05e-05	0.000403	CcSEcCtD
Fluconazole—Pruritus—Mycophenolate mofetil—psoriasis	4.04e-05	0.000402	CcSEcCtD
Fluconazole—Myalgia—Prednisone—psoriasis	4.04e-05	0.000402	CcSEcCtD
Fluconazole—Feeling abnormal—Triamcinolone—psoriasis	4.04e-05	0.000402	CcSEcCtD
Fluconazole—Alopecia—Methotrexate—psoriasis	4.02e-05	0.000401	CcSEcCtD
Fluconazole—Insomnia—Dexamethasone—psoriasis	4.02e-05	0.0004	CcSEcCtD
Fluconazole—Insomnia—Betamethasone—psoriasis	4.02e-05	0.0004	CcSEcCtD
Fluconazole—ABCB1—Allograft Rejection—IL12B—psoriasis	4.02e-05	0.00414	CbGpPWpGaD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	4.01e-05	0.000399	CcSEcCtD
Fluconazole—Diarrhoea—Cyclosporine—psoriasis	4e-05	0.000399	CcSEcCtD
Fluconazole—Paraesthesia—Dexamethasone—psoriasis	3.99e-05	0.000398	CcSEcCtD
Fluconazole—Paraesthesia—Betamethasone—psoriasis	3.99e-05	0.000398	CcSEcCtD
Fluconazole—Discomfort—Prednisone—psoriasis	3.99e-05	0.000397	CcSEcCtD
Fluconazole—Mental disorder—Methotrexate—psoriasis	3.99e-05	0.000397	CcSEcCtD
Fluconazole—Malnutrition—Methotrexate—psoriasis	3.96e-05	0.000395	CcSEcCtD
Fluconazole—Hypersensitivity—Prednisolone—psoriasis	3.92e-05	0.000391	CcSEcCtD
Fluconazole—ABCB1—Allograft Rejection—HLA-E—psoriasis	3.92e-05	0.00404	CbGpPWpGaD
Fluconazole—Dyspepsia—Betamethasone—psoriasis	3.91e-05	0.00039	CcSEcCtD
Fluconazole—Dyspepsia—Dexamethasone—psoriasis	3.91e-05	0.00039	CcSEcCtD
Fluconazole—Diarrhoea—Mycophenolate mofetil—psoriasis	3.91e-05	0.000389	CcSEcCtD
Fluconazole—Urticaria—Triamcinolone—psoriasis	3.89e-05	0.000388	CcSEcCtD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.88e-05	0.004	CbGpPWpGaD
Fluconazole—Dysgeusia—Methotrexate—psoriasis	3.88e-05	0.000387	CcSEcCtD
Fluconazole—Body temperature increased—Triamcinolone—psoriasis	3.87e-05	0.000386	CcSEcCtD
Fluconazole—Dizziness—Cyclosporine—psoriasis	3.87e-05	0.000386	CcSEcCtD
Fluconazole—Anaphylactic shock—Prednisone—psoriasis	3.87e-05	0.000386	CcSEcCtD
Fluconazole—Decreased appetite—Dexamethasone—psoriasis	3.86e-05	0.000385	CcSEcCtD
Fluconazole—Decreased appetite—Betamethasone—psoriasis	3.86e-05	0.000385	CcSEcCtD
Fluconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.86e-05	0.00398	CbGpPWpGaD
Fluconazole—Gastrointestinal disorder—Betamethasone—psoriasis	3.84e-05	0.000382	CcSEcCtD
Fluconazole—Gastrointestinal disorder—Dexamethasone—psoriasis	3.84e-05	0.000382	CcSEcCtD
Fluconazole—Back pain—Methotrexate—psoriasis	3.83e-05	0.000382	CcSEcCtD
Fluconazole—Hypersensitivity—Hydrocortisone—psoriasis	3.83e-05	0.000382	CcSEcCtD
Fluconazole—Fatigue—Dexamethasone—psoriasis	3.83e-05	0.000382	CcSEcCtD
Fluconazole—Fatigue—Betamethasone—psoriasis	3.83e-05	0.000382	CcSEcCtD
Fluconazole—Pain—Betamethasone—psoriasis	3.8e-05	0.000379	CcSEcCtD
Fluconazole—Pain—Dexamethasone—psoriasis	3.8e-05	0.000379	CcSEcCtD
Fluconazole—Nervous system disorder—Prednisone—psoriasis	3.8e-05	0.000378	CcSEcCtD
Fluconazole—Dizziness—Mycophenolate mofetil—psoriasis	3.78e-05	0.000376	CcSEcCtD
Fluconazole—Skin disorder—Prednisone—psoriasis	3.76e-05	0.000375	CcSEcCtD
Fluconazole—Hyperhidrosis—Prednisone—psoriasis	3.74e-05	0.000373	CcSEcCtD
Fluconazole—Asthenia—Hydrocortisone—psoriasis	3.73e-05	0.000372	CcSEcCtD
Fluconazole—Vomiting—Cyclosporine—psoriasis	3.72e-05	0.000371	CcSEcCtD
Fluconazole—Rash—Cyclosporine—psoriasis	3.69e-05	0.000368	CcSEcCtD
Fluconazole—Anorexia—Prednisone—psoriasis	3.69e-05	0.000368	CcSEcCtD
Fluconazole—Dermatitis—Cyclosporine—psoriasis	3.69e-05	0.000367	CcSEcCtD
Fluconazole—Pruritus—Hydrocortisone—psoriasis	3.68e-05	0.000367	CcSEcCtD
Fluconazole—Ill-defined disorder—Methotrexate—psoriasis	3.68e-05	0.000366	CcSEcCtD
Fluconazole—Headache—Cyclosporine—psoriasis	3.67e-05	0.000365	CcSEcCtD
Fluconazole—Anaemia—Methotrexate—psoriasis	3.66e-05	0.000365	CcSEcCtD
Fluconazole—Feeling abnormal—Dexamethasone—psoriasis	3.66e-05	0.000365	CcSEcCtD
Fluconazole—Feeling abnormal—Betamethasone—psoriasis	3.66e-05	0.000365	CcSEcCtD
Fluconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.65e-05	0.00376	CbGpPWpGaD
Fluconazole—Gastrointestinal pain—Betamethasone—psoriasis	3.63e-05	0.000362	CcSEcCtD
Fluconazole—Gastrointestinal pain—Dexamethasone—psoriasis	3.63e-05	0.000362	CcSEcCtD
Fluconazole—Vomiting—Mycophenolate mofetil—psoriasis	3.63e-05	0.000362	CcSEcCtD
Fluconazole—Hypersensitivity—Triamcinolone—psoriasis	3.61e-05	0.00036	CcSEcCtD
Fluconazole—Rash—Mycophenolate mofetil—psoriasis	3.6e-05	0.000359	CcSEcCtD
Fluconazole—Dermatitis—Mycophenolate mofetil—psoriasis	3.6e-05	0.000358	CcSEcCtD
Fluconazole—Headache—Mycophenolate mofetil—psoriasis	3.58e-05	0.000356	CcSEcCtD
Fluconazole—Malaise—Methotrexate—psoriasis	3.57e-05	0.000356	CcSEcCtD
Fluconazole—Vertigo—Methotrexate—psoriasis	3.56e-05	0.000355	CcSEcCtD
Fluconazole—Diarrhoea—Hydrocortisone—psoriasis	3.56e-05	0.000355	CcSEcCtD
Fluconazole—Leukopenia—Methotrexate—psoriasis	3.55e-05	0.000353	CcSEcCtD
Fluconazole—CYP11B1—Metabolism—CYP2S1—psoriasis	3.54e-05	0.00365	CbGpPWpGaD
Fluconazole—Urticaria—Betamethasone—psoriasis	3.53e-05	0.000352	CcSEcCtD
Fluconazole—Urticaria—Dexamethasone—psoriasis	3.53e-05	0.000352	CcSEcCtD
Fluconazole—Musculoskeletal discomfort—Prednisone—psoriasis	3.53e-05	0.000351	CcSEcCtD
Fluconazole—Dizziness—Prednisolone—psoriasis	3.52e-05	0.000351	CcSEcCtD
Fluconazole—Asthenia—Triamcinolone—psoriasis	3.51e-05	0.00035	CcSEcCtD
Fluconazole—Abdominal pain—Dexamethasone—psoriasis	3.51e-05	0.00035	CcSEcCtD
Fluconazole—Body temperature increased—Betamethasone—psoriasis	3.51e-05	0.00035	CcSEcCtD
Fluconazole—Body temperature increased—Dexamethasone—psoriasis	3.51e-05	0.00035	CcSEcCtD
Fluconazole—Abdominal pain—Betamethasone—psoriasis	3.51e-05	0.00035	CcSEcCtD
Fluconazole—Insomnia—Prednisone—psoriasis	3.5e-05	0.000349	CcSEcCtD
Fluconazole—Nausea—Cyclosporine—psoriasis	3.48e-05	0.000346	CcSEcCtD
Fluconazole—Paraesthesia—Prednisone—psoriasis	3.48e-05	0.000346	CcSEcCtD
Fluconazole—Pruritus—Triamcinolone—psoriasis	3.47e-05	0.000345	CcSEcCtD
Fluconazole—Dizziness—Hydrocortisone—psoriasis	3.44e-05	0.000343	CcSEcCtD
Fluconazole—Convulsion—Methotrexate—psoriasis	3.43e-05	0.000342	CcSEcCtD
Fluconazole—CYP3A4—Biological oxidations—CYP2S1—psoriasis	3.42e-05	0.00353	CbGpPWpGaD
Fluconazole—Dyspepsia—Prednisone—psoriasis	3.41e-05	0.000339	CcSEcCtD
Fluconazole—Nausea—Mycophenolate mofetil—psoriasis	3.39e-05	0.000338	CcSEcCtD
Fluconazole—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	3.38e-05	0.00348	CbGpPWpGaD
Fluconazole—Myalgia—Methotrexate—psoriasis	3.37e-05	0.000336	CcSEcCtD
Fluconazole—Decreased appetite—Prednisone—psoriasis	3.36e-05	0.000335	CcSEcCtD
Fluconazole—Rash—Prednisolone—psoriasis	3.36e-05	0.000335	CcSEcCtD
Fluconazole—Dermatitis—Prednisolone—psoriasis	3.35e-05	0.000334	CcSEcCtD
Fluconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	3.35e-05	0.000334	CcSEcCtD
Fluconazole—Fatigue—Prednisone—psoriasis	3.34e-05	0.000332	CcSEcCtD
Fluconazole—Headache—Prednisolone—psoriasis	3.34e-05	0.000332	CcSEcCtD
Fluconazole—Discomfort—Methotrexate—psoriasis	3.33e-05	0.000332	CcSEcCtD
Fluconazole—Constipation—Prednisone—psoriasis	3.31e-05	0.00033	CcSEcCtD
Fluconazole—Vomiting—Hydrocortisone—psoriasis	3.31e-05	0.00033	CcSEcCtD
Fluconazole—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	3.28e-05	0.00338	CbGpPWpGaD
Fluconazole—Rash—Hydrocortisone—psoriasis	3.28e-05	0.000327	CcSEcCtD
Fluconazole—Dermatitis—Hydrocortisone—psoriasis	3.28e-05	0.000326	CcSEcCtD
Fluconazole—Headache—Hydrocortisone—psoriasis	3.26e-05	0.000325	CcSEcCtD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	3.24e-05	0.00334	CbGpPWpGaD
Fluconazole—Dizziness—Triamcinolone—psoriasis	3.24e-05	0.000323	CcSEcCtD
Fluconazole—Anaphylactic shock—Methotrexate—psoriasis	3.23e-05	0.000322	CcSEcCtD
Fluconazole—Feeling abnormal—Prednisone—psoriasis	3.19e-05	0.000318	CcSEcCtD
Fluconazole—Asthenia—Betamethasone—psoriasis	3.19e-05	0.000318	CcSEcCtD
Fluconazole—Asthenia—Dexamethasone—psoriasis	3.19e-05	0.000318	CcSEcCtD
Fluconazole—Nervous system disorder—Methotrexate—psoriasis	3.17e-05	0.000316	CcSEcCtD
Fluconazole—Thrombocytopenia—Methotrexate—psoriasis	3.17e-05	0.000316	CcSEcCtD
Fluconazole—Gastrointestinal pain—Prednisone—psoriasis	3.16e-05	0.000315	CcSEcCtD
Fluconazole—Nausea—Prednisolone—psoriasis	3.16e-05	0.000315	CcSEcCtD
Fluconazole—Pruritus—Betamethasone—psoriasis	3.14e-05	0.000313	CcSEcCtD
Fluconazole—Pruritus—Dexamethasone—psoriasis	3.14e-05	0.000313	CcSEcCtD
Fluconazole—Skin disorder—Methotrexate—psoriasis	3.14e-05	0.000313	CcSEcCtD
Fluconazole—Hyperhidrosis—Methotrexate—psoriasis	3.13e-05	0.000312	CcSEcCtD
Fluconazole—Vomiting—Triamcinolone—psoriasis	3.11e-05	0.00031	CcSEcCtD
Fluconazole—Nausea—Hydrocortisone—psoriasis	3.09e-05	0.000308	CcSEcCtD
Fluconazole—Rash—Triamcinolone—psoriasis	3.09e-05	0.000308	CcSEcCtD
Fluconazole—Dermatitis—Triamcinolone—psoriasis	3.09e-05	0.000307	CcSEcCtD
Fluconazole—Anorexia—Methotrexate—psoriasis	3.08e-05	0.000307	CcSEcCtD
Fluconazole—Urticaria—Prednisone—psoriasis	3.07e-05	0.000306	CcSEcCtD
Fluconazole—Headache—Triamcinolone—psoriasis	3.07e-05	0.000306	CcSEcCtD
Fluconazole—Body temperature increased—Prednisone—psoriasis	3.06e-05	0.000305	CcSEcCtD
Fluconazole—Abdominal pain—Prednisone—psoriasis	3.06e-05	0.000305	CcSEcCtD
Fluconazole—Diarrhoea—Dexamethasone—psoriasis	3.04e-05	0.000303	CcSEcCtD
Fluconazole—Diarrhoea—Betamethasone—psoriasis	3.04e-05	0.000303	CcSEcCtD
Fluconazole—CYP3A4—Tryptophan metabolism—CAT—psoriasis	2.95e-05	0.00304	CbGpPWpGaD
Fluconazole—Musculoskeletal discomfort—Methotrexate—psoriasis	2.95e-05	0.000294	CcSEcCtD
Fluconazole—Dizziness—Dexamethasone—psoriasis	2.94e-05	0.000293	CcSEcCtD
Fluconazole—Dizziness—Betamethasone—psoriasis	2.94e-05	0.000293	CcSEcCtD
Fluconazole—ABCB1—Allograft Rejection—IL10—psoriasis	2.94e-05	0.00303	CbGpPWpGaD
Fluconazole—Insomnia—Methotrexate—psoriasis	2.93e-05	0.000291	CcSEcCtD
Fluconazole—Nausea—Triamcinolone—psoriasis	2.91e-05	0.00029	CcSEcCtD
Fluconazole—Paraesthesia—Methotrexate—psoriasis	2.9e-05	0.000289	CcSEcCtD
Fluconazole—Somnolence—Methotrexate—psoriasis	2.88e-05	0.000286	CcSEcCtD
Fluconazole—ABCB1—Allograft Rejection—IL4—psoriasis	2.86e-05	0.00294	CbGpPWpGaD
Fluconazole—Hypersensitivity—Prednisone—psoriasis	2.85e-05	0.000284	CcSEcCtD
Fluconazole—Dyspepsia—Methotrexate—psoriasis	2.85e-05	0.000284	CcSEcCtD
Fluconazole—Vomiting—Betamethasone—psoriasis	2.83e-05	0.000282	CcSEcCtD
Fluconazole—Vomiting—Dexamethasone—psoriasis	2.83e-05	0.000282	CcSEcCtD
Fluconazole—Decreased appetite—Methotrexate—psoriasis	2.81e-05	0.00028	CcSEcCtD
Fluconazole—Rash—Betamethasone—psoriasis	2.8e-05	0.000279	CcSEcCtD
Fluconazole—Rash—Dexamethasone—psoriasis	2.8e-05	0.000279	CcSEcCtD
Fluconazole—Dermatitis—Dexamethasone—psoriasis	2.8e-05	0.000279	CcSEcCtD
Fluconazole—Dermatitis—Betamethasone—psoriasis	2.8e-05	0.000279	CcSEcCtD
Fluconazole—ABCB1—Allograft Rejection—HLA-B—psoriasis	2.79e-05	0.00288	CbGpPWpGaD
Fluconazole—Gastrointestinal disorder—Methotrexate—psoriasis	2.79e-05	0.000278	CcSEcCtD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	2.79e-05	0.00288	CbGpPWpGaD
Fluconazole—Fatigue—Methotrexate—psoriasis	2.79e-05	0.000278	CcSEcCtD
Fluconazole—Headache—Dexamethasone—psoriasis	2.78e-05	0.000277	CcSEcCtD
Fluconazole—Headache—Betamethasone—psoriasis	2.78e-05	0.000277	CcSEcCtD
Fluconazole—Asthenia—Prednisone—psoriasis	2.78e-05	0.000277	CcSEcCtD
Fluconazole—Pain—Methotrexate—psoriasis	2.77e-05	0.000276	CcSEcCtD
Fluconazole—Pruritus—Prednisone—psoriasis	2.74e-05	0.000273	CcSEcCtD
Fluconazole—Feeling abnormal—Methotrexate—psoriasis	2.67e-05	0.000266	CcSEcCtD
Fluconazole—Diarrhoea—Prednisone—psoriasis	2.65e-05	0.000264	CcSEcCtD
Fluconazole—Gastrointestinal pain—Methotrexate—psoriasis	2.64e-05	0.000264	CcSEcCtD
Fluconazole—Nausea—Dexamethasone—psoriasis	2.64e-05	0.000263	CcSEcCtD
Fluconazole—Nausea—Betamethasone—psoriasis	2.64e-05	0.000263	CcSEcCtD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	2.6e-05	0.00268	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—HLA-A—psoriasis	2.59e-05	0.00267	CbGpPWpGaD
Fluconazole—Urticaria—Methotrexate—psoriasis	2.57e-05	0.000256	CcSEcCtD
Fluconazole—Dizziness—Prednisone—psoriasis	2.56e-05	0.000255	CcSEcCtD
Fluconazole—Body temperature increased—Methotrexate—psoriasis	2.56e-05	0.000255	CcSEcCtD
Fluconazole—Abdominal pain—Methotrexate—psoriasis	2.56e-05	0.000255	CcSEcCtD
Fluconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.55e-05	0.00262	CbGpPWpGaD
Fluconazole—Vomiting—Prednisone—psoriasis	2.46e-05	0.000245	CcSEcCtD
Fluconazole—Rash—Prednisone—psoriasis	2.44e-05	0.000243	CcSEcCtD
Fluconazole—Dermatitis—Prednisone—psoriasis	2.44e-05	0.000243	CcSEcCtD
Fluconazole—Headache—Prednisone—psoriasis	2.42e-05	0.000242	CcSEcCtD
Fluconazole—Hypersensitivity—Methotrexate—psoriasis	2.38e-05	0.000237	CcSEcCtD
Fluconazole—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	2.36e-05	0.00244	CbGpPWpGaD
Fluconazole—Asthenia—Methotrexate—psoriasis	2.32e-05	0.000231	CcSEcCtD
Fluconazole—Nausea—Prednisone—psoriasis	2.3e-05	0.000229	CcSEcCtD
Fluconazole—Pruritus—Methotrexate—psoriasis	2.29e-05	0.000228	CcSEcCtD
Fluconazole—Diarrhoea—Methotrexate—psoriasis	2.21e-05	0.00022	CcSEcCtD
Fluconazole—Dizziness—Methotrexate—psoriasis	2.14e-05	0.000213	CcSEcCtD
Fluconazole—Vomiting—Methotrexate—psoriasis	2.06e-05	0.000205	CcSEcCtD
Fluconazole—CYP3A7—Metabolism—NDUFA5—psoriasis	2.05e-05	0.00211	CbGpPWpGaD
Fluconazole—Rash—Methotrexate—psoriasis	2.04e-05	0.000203	CcSEcCtD
Fluconazole—Dermatitis—Methotrexate—psoriasis	2.04e-05	0.000203	CcSEcCtD
Fluconazole—Headache—Methotrexate—psoriasis	2.03e-05	0.000202	CcSEcCtD
Fluconazole—Nausea—Methotrexate—psoriasis	1.92e-05	0.000191	CcSEcCtD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.85e-05	0.00191	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CYP2S1—psoriasis	1.74e-05	0.0018	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—CARM1—psoriasis	1.73e-05	0.00178	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—IFNG—psoriasis	1.73e-05	0.00178	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	1.72e-05	0.00178	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.62e-05	0.00167	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.61e-05	0.00166	CbGpPWpGaD
Fluconazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.51e-05	0.00155	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—NDUFA5—psoriasis	1.48e-05	0.00153	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.32e-05	0.00136	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.3e-05	0.00134	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CYP2S1—psoriasis	1.26e-05	0.0013	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—NDUFA5—psoriasis	1.14e-05	0.00118	CbGpPWpGaD
Fluconazole—ABCB1—Allograft Rejection—TNF—psoriasis	1.12e-05	0.00115	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—NDUFA5—psoriasis	1.12e-05	0.00115	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.11e-05	0.00115	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.07e-05	0.0011	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—CAT—psoriasis	1.06e-05	0.0011	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—NDUFA5—psoriasis	1.04e-05	0.00108	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.04e-05	0.00107	CbGpPWpGaD
Fluconazole—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	9.91e-06	0.00102	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CYP2S1—psoriasis	9.73e-06	0.001	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.73e-06	0.001	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CYP2S1—psoriasis	9.5e-06	0.000979	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CYP2S1—psoriasis	8.88e-06	0.000915	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CARM1—psoriasis	8.51e-06	0.000877	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—APOE—psoriasis	8.26e-06	0.000852	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	7.37e-06	0.000759	CbGpPWpGaD
Fluconazole—CYP11B1—Metabolism—PPARG—psoriasis	7.2e-06	0.000742	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	7.09e-06	0.000731	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—NDUFA5—psoriasis	6.88e-06	0.00071	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	6.44e-06	0.000663	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CARM1—psoriasis	6.15e-06	0.000634	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CYP2S1—psoriasis	5.85e-06	0.000603	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	5.52e-06	0.000569	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—CAT—psoriasis	5.23e-06	0.000539	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.1e-06	0.000526	CbGpPWpGaD
Fluconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.86e-06	0.000501	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CARM1—psoriasis	4.75e-06	0.00049	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.65e-06	0.000479	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CARM1—psoriasis	4.64e-06	0.000478	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.44e-06	0.000458	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CARM1—psoriasis	4.33e-06	0.000447	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—APOE—psoriasis	4.07e-06	0.000419	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.05e-06	0.000418	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—CAT—psoriasis	3.78e-06	0.00039	CbGpPWpGaD
Fluconazole—CYP3A7—Metabolism—PPARG—psoriasis	3.54e-06	0.000365	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—APOE—psoriasis	2.94e-06	0.000303	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—CAT—psoriasis	2.92e-06	0.000301	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CARM1—psoriasis	2.86e-06	0.000295	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—CAT—psoriasis	2.85e-06	0.000294	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—CAT—psoriasis	2.67e-06	0.000275	CbGpPWpGaD
Fluconazole—CYP3A5—Metabolism—PPARG—psoriasis	2.56e-06	0.000264	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—APOE—psoriasis	2.27e-06	0.000234	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—APOE—psoriasis	2.22e-06	0.000229	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—APOE—psoriasis	2.07e-06	0.000214	CbGpPWpGaD
Fluconazole—CYP2C19—Metabolism—PPARG—psoriasis	1.98e-06	0.000204	CbGpPWpGaD
Fluconazole—ABCB1—Metabolism—PPARG—psoriasis	1.93e-06	0.000199	CbGpPWpGaD
Fluconazole—CYP2C9—Metabolism—PPARG—psoriasis	1.8e-06	0.000186	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—CAT—psoriasis	1.76e-06	0.000181	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—APOE—psoriasis	1.37e-06	0.000141	CbGpPWpGaD
Fluconazole—CYP3A4—Metabolism—PPARG—psoriasis	1.19e-06	0.000123	CbGpPWpGaD
